MUSREFCY Trademark

Trademark Overview


On Monday, September 3, 2018, a trademark application was filed for MUSREFCY with the United States Patent and Trademark Office. The USPTO has given the MUSREFCY trademark a serial number of 79249709. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 12, 2025. This trademark is owned by TAIHO PHARMACEUTICAL CO., LTD.. The MUSREFCY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoim...

General Information


Serial Number79249709
Word MarkMUSREFCY
Filing DateMonday, September 3, 2018
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 12, 2025
Registration Number5760113
Registration DateTuesday, May 28, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 12, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTAIHO PHARMACEUTICAL CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameTAIHO PHARMACEUTICAL CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameTAIHO PHARMACEUTICAL CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Thursday, January 17, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, January 22, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, January 23, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 23, 2019ASSIGNED TO EXAMINER
Tuesday, January 29, 2019APPLICATION FILING RECEIPT MAILED
Wednesday, January 30, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 20, 2019NOTICE OF PUBLICATION
Tuesday, March 12, 2019PUBLISHED FOR OPPOSITION
Tuesday, May 28, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, June 27, 2019GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Saturday, July 27, 2019FINAL DISPOSITION PROCESSED
Saturday, July 27, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 16, 2019NOTIFICATION PROCESSED BY IB
Friday, December 12, 2025CANCELLED SECTION 71